Who is sponsoring NCT04098601?

NCT04098601 is sponsored by Prisma Health-Upstate.

What drugs are being tested in NCT04098601?

Interventions in NCT04098601: Recovery Coach Intervention.

What condition does NCT04098601 study?

NCT04098601 studies Substance Use Disorders.

Is NCT04098601 still recruiting?

NCT04098601 is currently completed. Last updated 4 November 2024.

Last reviewed 2024-11-04 · How we verify

NCT04098601

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inpatient Link to Addiction Recovery

Completed NA Last updated 4 November 2024

What this trial tests

NA trial testing Recovery Coach Intervention in Substance Use Disorders in 103 participants. Completed in 30 December 2019.

Timeline

19 April 2018

Primary endpoint
30 December 2019

30 December 2019

Quick facts

Lead sponsor	Prisma Health-Upstate
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	103
Start date	19 April 2018
Primary completion	30 December 2019
Estimated completion	30 December 2019
Sites	1 location across United States

Drugs / interventions tested

Recovery Coach Intervention

Conditions studied

Substance Use Disorders — all drugs for Substance Use Disorders →

Sponsor

Prisma Health-Upstate — full company profile →

Who can join

18 and older, any sex, with Substance Use Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this proposal is to link inpatients to a certified peer support specialist through FAVOR-Greenville and determine the effectiveness of recovery coaching on patient outcomes.This study will evaluate the impact of initiating peer recovery coaching during SUD patients' hospitalization on engagement in recovery services, addiction severity, and quality of life compared to the current standard of care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Acute Care Utilization After Recovery Coaching Linkage During Substance-Related Inpatient Admission: Results of Two Randomized Controlled Trials.
Cupp JA, Byrne KA, Herbert K, Roth PJ. · · 2022 · cited 17× · PMID 35296984 · DOI 10.1007/s11606-021-07360-w

Verify or expand the search:

Other trials of Recovery Coach Intervention

Trials testing the same drug.

NCT04098614 — Barriers to Substance Use Disorder Recovery · NA · completed

Other recruiting trials for Substance Use Disorders

Currently open trials in the same condition.

NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
NCT07529327 — Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups an · NA · recruiting
NCT07281261 — tAN for Substance Use Disorder · NA · recruiting
NCT07210268 — Temporal Interference Methods for Addiction Treatment · NA · recruiting
NCT07146633 — Efficacy of an EMDR App for PTSD and SUD · NA · recruiting

Other Prisma Health-Upstate trials

Trials by the same sponsor.

NCT07202039 — Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine · NA · not yet recruiting
NCT07375212 — VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure · Phase 4 · withdrawn
NCT07102615 — Intracervical Vasopressin · Phase 4 · recruiting
NCT07101250 — Preoperative Acetazolamide · Phase 4 · recruiting
NCT06874413 — Targeted Prehabilitation With Physical Exercise and Inspiratory Muscle Training for Elderly Frail Patients Prior to Vent · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04098601 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prisma Health-Upstate
Last refreshed: 4 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04098601.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing